JARDIANCE and ZITUVIO are considered bioequivalent by the FDA

In 2023 the FDA approved ZITUVIO, a pharmaceutical alternative to JANUVIA. The FDA has deemed JANUVIA and ZITUVIO to be bioequivalent—this means they contain the same active ingredient and work in the same way.

ZITUVIO Provides Relief to Americans Needing Expensive DPP4 Drug Class

JANUVIA and TRADJENTA are part of a class of medications known as dipeptidyl peptidase-4 inhibitors, often abbreviated as DPP-4 inhibitors or referred to as “gliptins.”

Despite the effectiveness of medications like JANUVIA and TRADJENTA in managing type 2 diabetes, the retail price has left this class of medication beyond the financial means of many who need it,

Generic ZITUVIO costs 70% less than JANUVIA - just $80/month

ZITUVIO Approval Offers Alternative to JANUVIA

The FDA's nod to ZITUVIO is significant against the backdrop of safety concerns highlighted in 2022, relating to nitrosamine impurities, notably Nitroso-STG-19 (NTTP), found in select sitagliptin samples. Nitrosamines are identified as potential or probable human carcinogens, which could pose a risk of cancer. In response, Merck, the company behind JANUVIA, is in the process of investigating the issue of contamination.

In its journey to approval, ZITUVIO was subjected to extensive quality assessments, ensuring its freedom from these dangerous carcinogens.

This authorization positions ZITUVIO as a viable treatment alternative for individuals with type 2 diabetes, offering a solution to those concerned about the carcinogenic impurities detected in some sitagliptin-based medications.

See how JANUVIA and ZITUVIO compare.

About Generic Sitagliptin (ZITUVIO)

ZITUVIO is a medications designed to manage blood sugar levels in people with type 2 diabetes. Like JANUVIA, it contains an active ingredient called Sitagliptin. JANUVIA gained approval from the Food and Drug Administration (FDA) on October 16, 2006, while ZITUVIO received its approval more recently on Oct 20, 2023.

ZITUVIO is:

• Bioequivalent to JANUVIA
• Available in same dosages of 25, 50 and 100mg tablets
• Available nationwide in all 50 states

How Does the Price of Januvia® and ZITUVIO Compare?

ZITUVIO offers a more affordable option within the same therapeutic class as Januvia®. By using a direct-to-patient pharmacy model, unnecessary intermediaries such as wholesalers and insurance-related markups are avoided. This streamlined approach helps keep the monthly cost significantly lower while maintaining consistent access for patients. ZITUVIO is dispensed through a dedicated pharmacy partner and is not available at local retail pharmacies.

Accessing ZITUVIO at $80 per month* is simple and convenient, with no insurance required.

• No insurance required
• Nationwide free shipping
• Available to all patients*

Don't let the high cost of essential medications stand in your way. Choose generic sitagliptin (ZITUVIO) and experience relief without breaking the bank.

*With a valid prescription.

Don't have a prescription yet?

Download the form below to take to your next appointment. It will outline for your healthcare provider what generic ZITUVIO is and how to prescribe to Marley Drug.

Stock photos are used to represent actual testimonials of Marley Drug customers.